CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published ahead of print on January 17, 2007
Clinical Journal of the American Society of Nephrology
© 2007 American Society of Nephrology
doi: 10.2215/CJN.03280906
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.03280906v1
2/2/356    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jo, S. K.
Right arrow Articles by Okusa, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jo, S. K.
Right arrow Articles by Okusa, M. D.

MINI-REVIEWS

Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven’t Worked and What Is on the Horizon

Sang Kyung Jo , Mitchell H. Rosner , and Mark D. Okusa 1

Department of Medicine, University of Virginia, Charlottesville, Virginia


1 To whom correspondence should be addressed. E-mail: mdo7y{at}virginia.edu.


  Abstract

Current strategies to limit the extent of injury in acute renal failure are based on extensive studies that identified cellular and molecular mechanisms of acute kidney injury. Despite successes in various animal models, translation to human studies has failed or studies are inconclusive. This review describes past failures and barriers to successful clinical trials. It also focuses on promising preclinical studies using novel compounds that currently are in or close to human investigation. Implementation of previous or novel compounds in well-designed clinical trials provides hope for the successful treatment of this devastating disorder.


This article has been cited by other articles:


Home page
 CirculationHome page
P. A. McCullough and J. A. Tumlin
Prostaglandin-Based Renal Protection Against Contrast-Induced Acute Kidney Injury
Circulation, November 3, 2009; 120(18): 1749 - 1751.
[Full Text] [PDF]

Home page
 CJASNHome page
S. U. Nigwekar, S. D. Navaneethan, C. R. Parikh, and J. K. Hix
Atrial Natriuretic Peptide for Management of Acute Kidney Injury: A Systematic Review and Meta-analysis
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 261 - 272.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
N. Lameire, W. Van Biesen, E. Hoste, and R. Vanholder
The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI
NDT Plus, December 1, 2008; 1(6): 392 - 402.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. Bennett, C. L. Dent, Q. Ma, S. Dastrala, F. Grenier, R. Workman, H. Syed, S. Ali, J. Barasch, and P. Devarajan
Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 665 - 673.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
M. H. Rosner, D. Portilla, and M. D. Okusa
Analytic Reviews: Cardiac Surgery as a Cause of Acute Kidney Injury: Pathogenesis and Potential Therapies
J Intensive Care Med, January 1, 2008; 23(1): 3 - 18.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society of Nephrology.